Two Sigma Securities’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Two Sigma Securities's IONS Position: Q3 2026 in Review
Two Sigma Securities opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 9,581 shares worth $428K. The stake represents 0.03% of the portfolio and ranks #694 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in IONS as recently as Q4 2025.
Two Sigma Securities first reported a position in IONS in Q2 2017 and has held it in 14 quarters since. The position peaked at $3.82M in Q2 2024. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Two Sigma Securities held 9,581 shares of Ionis Pharmaceuticals worth $428K as of Q3 2026.
- Ionis Pharmaceuticals was a new Two Sigma Securities position in Q3 2026.
- Ionis Pharmaceuticals made up 0.03% of Two Sigma Securities's portfolio in Q3 2026, its #694 holding.
- Two Sigma Securities first reported a position in Ionis Pharmaceuticals in Q2 2017 and has held it in 14 quarters since.
- Two Sigma Securities's Ionis Pharmaceuticals position peaked at $3.82M in Q2 2024.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Two Sigma Securities's 13F filing for Q3 2026, filed 16 Nov 2026.